Literature DB >> 24949982

Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression.

Fabio Dall'Olio1, Nadia Malagolini2, Marco Trinchera3, Mariella Chiricolo2.   

Abstract

BACKGROUND: Glycosylation is increasingly recognized as one of the most relevant postranslational modifications. Sialic acids are negatively charged sugars which frequently terminate the carbohydrate chains of glycoproteins and glycolipids. The addition of sialic acids is mediated by sialyltransferases, a family of glycosyltransferases with a crucial role in cancer progression. SCOPE OF THE REVIEW: To describe the phenotypic and clinical implications of altered expression of sialyltransferases and of their cognate sialylated structures in cancer. To propose a unifying model of the role of sialyltransferases and sialylated structures on cancer progression. MAJOR
CONCLUSIONS: We first discuss the biosynthesis and the role played by the major cancer-associated sialylated structures, including Thomsen-Friedenreich-associated antigens, sialyl Lewis antigens, α2,6-sialylated lactosamine, polysialic acid and gangliosides. Then, we show that altered sialyltransferase expression in cancer, consequence of genetic and epigenetic alterations, generates a flow of information toward the membrane through the biosynthesis of aberrantly sialylated molecules (inside-out signaling). In turn, the presence of aberrantly sialylated structures on cell membrane receptors generates a flow of information toward the nucleus, which can exacerbate the neoplastic phenotype (outside-in signaling). We provide examples of self-fueling loops generated by these flows of information. GENERAL SIGNIFICANCE: Sialyltransferases have a wide impact on the biology of cancer and can be the target of innovative therapies. Our unified view provides a conceptual framework to understand the impact of altered glycosylation in cancer.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemoresistance; Gangliosides; Glycosylation; Integrins; Neural cell adhesion molecule; Sialylation

Mesh:

Substances:

Year:  2014        PMID: 24949982     DOI: 10.1016/j.bbagen.2014.06.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  53 in total

1.  Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.

Authors:  Haitham A Badr; Dina M M AlSadek; Mohit P Mathew; Chen-Zhong Li; Leyla B Djansugurova; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2015-08-10       Impact factor: 12.479

2.  The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.

Authors:  Colleen M Britain; Kaitlyn A Dorsett; Susan L Bellis
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

Review 3.  Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Authors:  Haitham A Badr; Dina M M AlSadek; Motawa E El-Houseini; Christopher T Saeui; Mohit P Mathew; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

4.  Tissue-Specific Glycosylation at the Glycopeptide Level.

Authors:  Katalin F Medzihradszky; Krista Kaasik; Robert J Chalkley
Journal:  Mol Cell Proteomics       Date:  2015-05-20       Impact factor: 5.911

Review 5.  Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.

Authors:  Heinz Läubli; Ajit Varki
Journal:  Cell Mol Life Sci       Date:  2019-09-04       Impact factor: 9.261

6.  ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.

Authors:  Andrew T Holdbrooks; Colleen M Britain; Susan L Bellis
Journal:  J Biol Chem       Date:  2017-12-12       Impact factor: 5.157

7.  A complex between phosphatidylinositol 4-kinase IIα and integrin α3β1 is required for N-glycan sialylation in cancer cells.

Authors:  Tomoya Isaji; Sanghun Im; Akihiko Kameyama; Yuqin Wang; Tomohiko Fukuda; Jianguo Gu
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

Review 8.  Galectin-Binding O-Glycosylations as Regulators of Malignancy.

Authors:  Charles J Dimitroff
Journal:  Cancer Res       Date:  2015-07-29       Impact factor: 12.701

9.  The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.

Authors:  Robert B Jones; Kaitlyn A Dorsett; Anita B Hjelmeland; Susan L Bellis
Journal:  J Biol Chem       Date:  2018-02-23       Impact factor: 5.157

10.  Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.

Authors:  Elizaveta Katorcha; Saurabh Srivastava; Nina Klimova; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2016-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.